March 17, 2015 at 01:54PM FDA to Hold Public Meeting on Alternative In Vitro Bioequivalence Pathways

On April 16, 2015, the U.S. Food and Drug Administration will sponsor a public meeting to discuss the use of in vitro methods as a mechanism for assessing the in vivo product bioequivalence (BE) of non-systemically absorbed (locally acting) drug products intended for use in veterinary species.



via What's New: Animal & Veterinary http://ift.tt/1AT04AD